DK1261625T3 - Memnopeptider, en fremgangsmåde til deres fremstilling og deres anvendelse - Google Patents

Memnopeptider, en fremgangsmåde til deres fremstilling og deres anvendelse

Info

Publication number
DK1261625T3
DK1261625T3 DK01923574T DK01923574T DK1261625T3 DK 1261625 T3 DK1261625 T3 DK 1261625T3 DK 01923574 T DK01923574 T DK 01923574T DK 01923574 T DK01923574 T DK 01923574T DK 1261625 T3 DK1261625 T3 DK 1261625T3
Authority
DK
Denmark
Prior art keywords
memnopeptides
preparation
Prior art date
Application number
DK01923574T
Other languages
English (en)
Inventor
Laszlo Vertesy
Herbert Kogler
Matthias Schiell
Astrid Markus
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1261625T3 publication Critical patent/DK1261625T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK01923574T 2000-02-29 2001-02-15 Memnopeptider, en fremgangsmåde til deres fremstilling og deres anvendelse DK1261625T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00104114A EP1130027A1 (de) 2000-02-29 2000-02-29 Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben

Publications (1)

Publication Number Publication Date
DK1261625T3 true DK1261625T3 (da) 2006-04-18

Family

ID=8167973

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01923574T DK1261625T3 (da) 2000-02-29 2001-02-15 Memnopeptider, en fremgangsmåde til deres fremstilling og deres anvendelse

Country Status (30)

Country Link
US (1) US6627604B2 (da)
EP (2) EP1130027A1 (da)
JP (1) JP4787449B2 (da)
KR (1) KR100997073B1 (da)
CN (1) CN1274715C (da)
AR (1) AR029808A1 (da)
AT (1) ATE313556T1 (da)
AU (2) AU5031801A (da)
BR (1) BR0108757A (da)
CA (1) CA2401032C (da)
CY (1) CY1105550T1 (da)
CZ (1) CZ303552B6 (da)
DE (1) DE60116063T2 (da)
DK (1) DK1261625T3 (da)
EE (1) EE05406B1 (da)
ES (1) ES2254394T3 (da)
HK (1) HK1052712B (da)
HR (1) HRP20020703B1 (da)
HU (1) HU228067B1 (da)
IL (2) IL151458A0 (da)
ME (1) ME00379B (da)
MX (1) MXPA02007845A (da)
NO (1) NO329082B1 (da)
NZ (1) NZ521036A (da)
PL (1) PL206818B1 (da)
RU (1) RU2261254C2 (da)
SI (1) SI1261625T1 (da)
SK (1) SK287310B6 (da)
WO (1) WO2001064715A2 (da)
ZA (1) ZA200206841B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1308613B1 (it) * 1999-02-17 2002-01-09 Pharmacia & Upjohn Spa Acidi grassi essenziali nella prevenzione di eventi cardiovascolari.
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
DE10050091A1 (de) * 2000-10-09 2002-04-25 Biotechnolog Forschung Gmbh Casein-Peptidfragmente mit wachstumsbeeinflußender Aktivität auf Zellkulturen
ITMI20010129A1 (it) * 2001-01-25 2002-07-25 Pharmacia & Upjohn Spa Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco
DE10258650A1 (de) * 2002-12-13 2004-06-24 Aventis Pharma Deutschland Gmbh Neue Spirobenzofuranlactame und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben
US7160917B2 (en) * 2002-12-13 2007-01-09 Sanofi-Aventis Deutschland Gmbh Spirobenzofuran lactams and their derivatives, processes for their preparation and use thereof
DE202012012998U1 (de) 2011-08-31 2014-06-13 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995004530A1 (en) * 1993-08-06 1995-02-16 Smithkline Beecham Corporation Endothelin receptor antagonists
JPH07330622A (ja) * 1994-06-06 1995-12-19 Asahi Chem Ind Co Ltd 新規生理活性物質スタキボシンｄ及びその製法
JPH08283118A (ja) * 1995-04-07 1996-10-29 Kao Corp 美白剤
JPH10251262A (ja) * 1997-01-13 1998-09-22 Mercian Corp プロテアーゼ阻害物質およびその製造方法
DE19731571A1 (de) * 1997-07-23 1999-01-28 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
DE19754082A1 (de) * 1997-12-05 1999-06-10 Knoll Ag Methode zur Bekämpfung der Fettleibigkeit
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben

Also Published As

Publication number Publication date
NZ521036A (en) 2004-02-27
HRP20020703B1 (en) 2011-01-31
AR029808A1 (es) 2003-07-16
EP1261625B1 (en) 2005-12-21
JP2004512257A (ja) 2004-04-22
CZ303552B6 (cs) 2012-12-05
US6627604B2 (en) 2003-09-30
KR20020077508A (ko) 2002-10-11
NO20024105D0 (no) 2002-08-28
CA2401032C (en) 2012-04-10
ATE313556T1 (de) 2006-01-15
RU2002125877A (ru) 2004-01-10
KR100997073B1 (ko) 2010-11-30
HU228067B1 (en) 2012-09-28
EE200200480A (et) 2004-02-16
NO20024105L (no) 2002-10-28
CA2401032A1 (en) 2001-09-07
IL151458A0 (en) 2003-04-10
HK1052712A1 (en) 2003-09-26
DE60116063T2 (de) 2006-08-03
HUP0204584A2 (hu) 2003-04-28
EE05406B1 (et) 2011-04-15
HRP20020703A2 (en) 2004-12-31
CY1105550T1 (el) 2010-07-28
CN1406243A (zh) 2003-03-26
US20010031857A1 (en) 2001-10-18
DE60116063D1 (de) 2006-01-26
AU2001250318B2 (en) 2005-09-08
RU2261254C2 (ru) 2005-09-27
EP1130027A1 (de) 2001-09-05
CZ20022904A3 (cs) 2002-11-13
CN1274715C (zh) 2006-09-13
WO2001064715A2 (en) 2001-09-07
JP4787449B2 (ja) 2011-10-05
MXPA02007845A (es) 2002-11-29
SI1261625T1 (sl) 2006-04-30
ZA200206841B (en) 2003-07-03
PL358300A1 (en) 2004-08-09
WO2001064715A3 (en) 2002-03-21
EP1261625A2 (en) 2002-12-04
NO329082B1 (no) 2010-08-16
ES2254394T3 (es) 2006-06-16
SK287310B6 (sk) 2010-06-07
HK1052712B (zh) 2007-01-12
IL151458A (en) 2008-08-07
HUP0204584A3 (en) 2005-09-28
BR0108757A (pt) 2002-12-10
AU5031801A (en) 2001-09-12
SK12262002A3 (sk) 2003-02-04
PL206818B1 (pl) 2010-09-30
MEP59108A (en) 2011-05-10
ME00379B (me) 2011-05-10

Similar Documents

Publication Publication Date Title
DK1381605T3 (da) Mercaptoacetylamidderivater, en fremgangsmåde til deres fremstilling og deres anvendelse
DK1294682T3 (da) Acylphenylurinstofderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
NO20024742D0 (no) Heterocykliske forbindelser, deres fremstilling og anvendelse
NO20015156L (no) 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
DK1455785T3 (da) Substituerede 2-thio-3,5-dicyano-4-phenyl-6-aminopyridiner og deres anvendelse
NO20014603D0 (no) Tienopyrimidinforbindelser, deres fremstilling og anvendelse
NO20021449L (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse
DK1315881T3 (da) Metode og system til perforering
NO20032893D0 (no) Urtepreparat for angina pectoris, fremstilling og anvendelse derav
NO20025357D0 (no) Antranylamider og deres anvendelse som legemidler
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
DE60103427D1 (de) Übereinstimmungssteuerverfahren
DK1265482T3 (da) Vandige formulationer og fremgangsmåde til fremstilling af samme
NO20031838D0 (no) Benzokazinonderivater, deres fremstilling og anvendelse
DK1261697T3 (da) Kuldeaktiv beta-galactosidase, fremgangsmåde til fremstilling heraf og anvendelsen deraf
FI20002466A (fi) Tunnistusmenetelmä
DK1261625T3 (da) Memnopeptider, en fremgangsmåde til deres fremstilling og deres anvendelse
NO20025209L (no) Cyklipostiner, deres fremstilling og anvendelse
DK1086077T3 (da) Hidtil ukendte antiestrogener, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
DK1261603T3 (da) Flavonderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
DK1053224T3 (da) Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
NO20024107L (no) Tienopyridin derivater, deres fremstilling og anvendelse
NO20006479D0 (no) Tienopyridinforbindelser, deres fremstilling og anvendelse
NO20033965L (no) Caloporosidderivater, fremgangsmåte for deres fremstilling og deres anvendelse
DK1404663T3 (da) Eurotinoner og derivater deraf, fremgangsmåde til deres fremstilling og anvendelse heraf